Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Anavex Life Sciences (GB:0HFR)
LSE:0HFR
Anavex Life Sciences (0HFR) Share Price & Analysis
0 Followers
0HFR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$7.61 - $14.80
Previous Close$9.15
Volume1.93K
Average Volume (3M)2.49K
Market Cap
$746.94M
Enterprise Value$593.47M
Total Cash (Recent Filing)$153.47M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-13.5
Beta0.62
Next Earnings
Aug 10, 2023EPS Estimate
-$0.18Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.68
Shares Outstanding80,837,723
10 Day Avg. Volume116
30 Day Avg. Volume2,494
Standard Deviation0.26
R-Squared0.02
Alpha0.06
Financial Highlights & Ratios
Price to Book (P/B)5.61
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-32.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-10.40
Forecast
1Y Price Target
$45.00Price Target Upside391.80% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Anavex Life Sciences News
0HFR FAQ
What was Anavex Life Sciences’s price range in the past 12 months?
Anavex Life Sciences lowest share price was $7.61 and its highest was $14.79 in the past 12 months.
What is Anavex Life Sciences’s market cap?
Currently, no data Available
When is Anavex Life Sciences’s upcoming earnings report date?
Anavex Life Sciences’s upcoming earnings report date is Aug 10, 2023 which is in 61 days.
How were Anavex Life Sciences’s earnings last quarter?
Anavex Life Sciences released its earnings results on May 09, 2023. The company reported -$0.17 earnings per share for the quarter, beating the consensus estimate of -$0.188 by $0.018.
Is Anavex Life Sciences overvalued?
According to Wall Street analysts Anavex Life Sciences’s price is currently Undervalued.
Does Anavex Life Sciences pay dividends?
Anavex Life Sciences does not currently pay dividends.
What is Anavex Life Sciences’s EPS estimate?
Anavex Life Sciences’s EPS estimate is -$0.18.
How many shares outstanding does Anavex Life Sciences have?
Anavex Life Sciences has 80,837,720 shares outstanding.
What happened to Anavex Life Sciences’s price movement after its last earnings report?
Anavex Life Sciences reported an EPS of -$0.17 in its last earnings report, beating expectations of -$0.188. Following the earnings report the stock price went up 6.641%.
Which hedge fund is a major shareholder of Anavex Life Sciences?
Among the largest hedge funds holding Anavex Life Sciences’s share is Sheaff Brock Investment Advisors LLC. It holds Anavex Life Sciences’s shares valued at 186K.
---
Anavex Life Sciences Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$45.00 (391.80% Upside)
$45.00 (391.80% Upside)
Blogger Sentiment
Bullish
GB:0HFR Sentiment 66%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
2.21%
12-Months-Change
Fundamentals
Return on Equity
-35.47%
Trailing 12-Months
Asset Growth
-0.68%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Anavex Life Sciences
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.
---
Anavex Life Sciences
―
Axsome Therapeutics
―
Kala Pharmaceuticals
―
Insmed
―
Amicus
―
---